Literature DB >> 30187869

[Expression of interleukin-9 in colon cancer tissues and its clinical significance].

Jin Wang1, Xiaoqiang Dong1, Xinguo Zhu1, Hua Zhao1, Deli Mao1, Xin Zhao1.   

Abstract

OBJECTIVE: To investigate the expression of interleukin-9 (IL-9) in colon cancer tissues and its clinical significance.
METHODS: Immunohistochenmistry and qRT-PCR were used to detect the expressions of IL-9 protein and mRNA in 92 colon cancer tissues and paired adjacent normal tissues. The correlation of IL-9 expressions with the clinicopathological features and prognosis of the patients was analyzed.
RESULTS: IL-9 protein and mRNA expressions were significantly higher in adjacent normal tissues than in the colon cancer tissues (P < 0.001). In colon cancer patients, IL-9 expression was significantly correlated with TNM stage (P=0.013), Ducks stage (P=0.025) and lymph node metastasis (P=0.004) but not with gender, age, tumor size, differentiation or hepatic metastasis (P > 0.05). The survival time of colon cancer patients with positive IL-9 expression was significantly longer than that of patients negative for IL-9 expression (P=0.015).
CONCLUSIONS: IL-9 expression is lowered in colon cancer tissues compoved with in the adjacent normal tissues. IL-9 expression is negatively correlated with TNM staging, Ducks staging and lymph node metastasis but positively with good prognosis, suggesting its important role in the tumor microenvironment of colon cancer.

Entities:  

Keywords:  colon cancer; immunohistochemistry; interleukin-9; prog

Mesh:

Substances:

Year:  2018        PMID: 30187869      PMCID: PMC6744043          DOI: 10.3969/j.issn.1673-4254.2018.08.07

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  26 in total

1.  Breakthrough of the year 2013. Cancer immunotherapy.

Authors:  Jennifer Couzin-Frankel
Journal:  Science       Date:  2013-12-20       Impact factor: 47.728

2.  IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL.

Authors:  Yujiang Fang; Xuhui Chen; Qian Bai; Chenglu Qin; Abdimalik O Mohamud; Ziwen Zhu; Tyler W Ball; Caleb M Ruth; Dylan R Newcomer; Elizabeth J Herrick; Michael B Nicholl
Journal:  J Surg Oncol       Date:  2015-05-18       Impact factor: 3.454

3.  IL-9 and its receptor are predominantly involved in the pathogenesis of UC.

Authors:  Nancy Nalleweg; Mircea Teodor Chiriac; Eva Podstawa; Christian Lehmann; Tilman T Rau; Raja Atreya; Ekaterina Krauss; Gheorghe Hundorfean; Stefan Fichtner-Feigl; Arndt Hartmann; Christoph Becker; Jonas Mudter
Journal:  Gut       Date:  2014-06-23       Impact factor: 23.059

4.  Does patient rurality predict quality colon cancer care?: A population-based study.

Authors:  Christopher J Chow; Waddah B Al-Refaie; Anasooya Abraham; Abraham Markin; Wei Zhong; David A Rothenberger; Mary R Kwaan; Elizabeth B Habermann
Journal:  Dis Colon Rectum       Date:  2015-04       Impact factor: 4.585

5.  IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.

Authors:  Guoyan Cheng; Aixin Yu; Michael J Dee; Thomas R Malek
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

Review 6.  Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases.

Authors:  Hai-Feng Pan; Rui-Xue Leng; Xiang-Pei Li; Song Guo Zheng; Dong-Qing Ye
Journal:  Cytokine Growth Factor Rev       Date:  2013-12       Impact factor: 7.638

7.  Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis.

Authors:  L Ma; H-B Xue; X-H Guan; C-M Shu; J-H Zhang; J Yu
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

8.  The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.

Authors:  Frédérique Végran; Hélène Berger; Romain Boidot; Grégoire Mignot; Mélanie Bruchard; Magalie Dosset; Fanny Chalmin; Cédric Rébé; Valentin Dérangère; Bernhard Ryffel; Masashi Kato; Armelle Prévost-Blondel; François Ghiringhelli; Lionel Apetoh
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4(+) T Cells.

Authors:  Yu Wang; Yujing Bi; Xi Chen; Chunxiao Li; Yan Li; Zhengguo Zhang; Jian Wang; Yun Lu; Qing Yu; Huilin Su; Hui Yang; Guangwei Liu
Journal:  Immunity       Date:  2016-06-14       Impact factor: 31.745

View more
  2 in total

Review 1.  TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer.

Authors:  Guanglin Cui
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

2.  Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.

Authors:  María Belén Novoa Díaz; Pedro Carriere; Graciela Gigola; Ariel Osvaldo Zwenger; Natalia Calvo; Claudia Gentili
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.